MCID: HLR001
MIFTS: 16

Hilar Lung Neoplasm

Categories: Cancer diseases, Respiratory diseases

Aliases & Classifications for Hilar Lung Neoplasm

MalaCards integrated aliases for Hilar Lung Neoplasm:

Name: Hilar Lung Neoplasm 12
Neoplasm of Hilus of Lung 12 69
Hilar Lung Carcinoma 12
Lung Hilum Carcinoma 69
Lung Hilum Tumor 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5767 DOID:8207
NCIt 47 C5671 C7454
SNOMED-CT 64 126707007

Summaries for Hilar Lung Neoplasm

MalaCards based summary : Hilar Lung Neoplasm, also known as neoplasm of hilus of lung, is related to lung hilum cancer. The drugs Celecoxib and Analgesics have been mentioned in the context of this disorder. Affiliated tissues include lung and lymph node.

Related Diseases for Hilar Lung Neoplasm

Diseases related to Hilar Lung Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 lung hilum cancer 11.1

Symptoms & Phenotypes for Hilar Lung Neoplasm

Drugs & Therapeutics for Hilar Lung Neoplasm

Drugs for Hilar Lung Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 34)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Celecoxib Approved, Investigational Phase 3 169590-42-5 2662
2 Analgesics Phase 3
3 Analgesics, Non-Narcotic Phase 3
4 Anti-Inflammatory Agents Phase 3
5 Anti-Inflammatory Agents, Non-Steroidal Phase 3
6 Antirheumatic Agents Phase 3
7 Cyclooxygenase 2 Inhibitors Phase 3
8 Cyclooxygenase Inhibitors Phase 3
9 Peripheral Nervous System Agents Phase 3
10
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
11
Carboplatin Approved Phase 1, Phase 2,Early Phase 1 41575-94-4 10339178 498142 38904
12
Cisplatin Approved Phase 1, Phase 2,Early Phase 1 15663-27-1 84093 441203 2767
13
Etoposide Approved Phase 1, Phase 2 33419-42-0 36462
14 Protein Kinase Inhibitors Phase 2
15 Antibodies Phase 1, Phase 2
16 Antibodies, Monoclonal Phase 1, Phase 2
17 Antineoplastic Agents, Phytogenic Phase 1, Phase 2,Early Phase 1
18 Etoposide phosphate Phase 1, Phase 2
19 Immunoglobulins Phase 1, Phase 2
20 Topoisomerase Inhibitors Phase 1, Phase 2
21
Paclitaxel Approved, Vet_approved Early Phase 1 33069-62-4 36314
22
Pemetrexed Approved, Investigational Early Phase 1 150399-23-8, 137281-23-3 446556 60843
23
Folic Acid Approved, Nutraceutical, Vet_approved Early Phase 1 59-30-3 6037
24
leucovorin Approved, Nutraceutical Early Phase 1 58-05-9 143 6006
25
Docetaxel Approved May 1996, Investigational Early Phase 1 114977-28-5 148124 9877265
26 Anesthetics
27 Central Nervous System Depressants
28 Albumin-Bound Paclitaxel Early Phase 1
29 Antimitotic Agents Early Phase 1
30 Folic Acid Antagonists Early Phase 1
31 Nucleic Acid Synthesis Inhibitors Early Phase 1
32 Vitamin B Complex Early Phase 1
33 Folate Nutraceutical Early Phase 1
34 Vitamin B9 Nutraceutical Early Phase 1

Interventional clinical trials:

(show all 27)

id Name Status NCT ID Phase Drugs
1 Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies Completed NCT01658280 Phase 4
2 Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer Completed NCT00003831 Phase 3
3 Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients Suspended NCT00211952 Phase 3 celecoxib
4 Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer Completed NCT00003692 Phase 2
5 Endobronchial Ultrasound vs Mediastinoscopy in NSCLC Completed NCT00372203 Phase 2
6 Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC Completed NCT00188617 Phase 2 GEFITINIB
7 QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer Completed NCT00791154 Phase 1, Phase 2 AMG 479;Etoposide;Placebo;AMG 102;Carboplatin;Cisplatin
8 SABR for T1-2a N1 NSCLC Not yet recruiting NCT03321760 Phase 2
9 Evaluation of the LungPoint Virtual Bronchoscopic Navigation (VBN) System Unknown status NCT01067755
10 Linear Endosonography for the Assessment of Sarcoidosis Stage O Unknown status NCT01383226
11 Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC) Completed NCT01079520
12 The Role of Sedation Technique in EBUS-TBNA Completed NCT02245295
13 Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy Completed NCT00915330
14 Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials Completed NCT00500513
15 Optical Biopsy for Thoracic Lymph Nodes. Completed NCT02689050
16 The Analysis of the EBUS Scope as a Hybrid Bronchoscope Completed NCT02360306
17 Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered Recruiting NCT02997449
18 Extensive Staging in Lung Cancer Recruiting NCT02030444
19 Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT) Recruiting NCT01786590
20 Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA Recruiting NCT02813603
21 Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer Recruiting NCT02568033 Early Phase 1 Pemetrexed;Carboplatin;Cisplatin;Docetaxel;Paclitaxel
22 EBUS-TBNA vs Flex 19G EBUS-TBNA Recruiting NCT02592837
23 Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC. A Randomised Controlled Trial Recruiting NCT03188562
24 EBUS-TBNA vs Flex 19G EBUS-TBNA Recruiting NCT02916459
25 Multicentric Analysis of Predictors of N1 Upstaging After Resection of cStage-I NSCLC Enrolling by invitation NCT02730897
26 Interest of Procore Needle® for Diagnosis of Lung Cancer Not yet recruiting NCT02931461
27 Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC Not yet recruiting NCT02718365

Search NIH Clinical Center for Hilar Lung Neoplasm

Genetic Tests for Hilar Lung Neoplasm

Anatomical Context for Hilar Lung Neoplasm

MalaCards organs/tissues related to Hilar Lung Neoplasm:

39
Lung, Lymph Node

Publications for Hilar Lung Neoplasm

Variations for Hilar Lung Neoplasm

Expression for Hilar Lung Neoplasm

Search GEO for disease gene expression data for Hilar Lung Neoplasm.

Pathways for Hilar Lung Neoplasm

GO Terms for Hilar Lung Neoplasm

Sources for Hilar Lung Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....